Skip to main content

Advertisement

Table 5 Serum concentrations of FBS, Insulin, HbA1c, MDA, TAC and measurements of HOMA-IR, HOMA-β in the curcumin treated and control group

From: The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial

Parameters Time Curcumin group (sd ± mean) Control group (sd ± mean) P2
FBS (mg/dl) Baseline 160 ± 35 144 ± 40.6 0.28
Week 10 153 ± 33 147 ± 40.4 0.67
P1 0.05 0.3  
Mean changes − 7 ± 2 3 ± 0.2 0.02
Insulin (mU/L) Baseline 9.2 ± 9 8.3 ± 6 0.70
Week 10 9.4 ± 6 9.7 ± 4.7 0.88
P1 0.9 0.3  
Mean changes 0.2 ± 3 1.4 ± 1.3 0.65
HbA1c (%) Baseline 11.3 ± 1.6 11.2 ± 1.3 0.84
Week 10 11 ± 2 11.1 ± 1.8 0.82
P1 0.3 0.3  
Mean changes − 0.3 ± 0.4 0.1 ± 0.5 0.65
HOMA-IR Baseline 62 ± 63 53 ± 40 0.58
Week 10 62.4 ± 42 65 ± 44 0.82
P1 0.9 0.1  
Mean changes 0.4 ± 21 12 ± 4 0.50
HOMA-B Baseline 131 ± 119 128 ± 103 0.94
Week 10 134 ± 98 140 ± 66 0.80
P1 0.5 0.09  
Mean changes 3 ± 21 12 ± 37 0.81
MDA (µmol/L) Baseline 7.5 ± 1.6 7.5 ± 1.6 0.92
Week 10 8 ± 1.7 8 ± 1.7 0.51
P1 0.2 0.1  
Mean changes 0.5 ± 0.1 0.5 ± 0.1 0.53
TAC (U/mL) Baseline 0.81 ± 0.11 0.7 ± 0.1 0.58
Week 10 0.8 ± 0.1 0.8 ± 0.1 0.70
P1 0.2 0.4  
Mean changes − 0.01 ± 0.01 0.1 ± 0 0.07
  1. P1: obtained from paired t-test P (p: 0.05)
  2. P2: obtained from Independent sample t-test (p: 0.05)